Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Is the launch environment really more competitive now?

Lilly holds off on tirzepatide filing in obesity, waiting for second trial

Meet Florence, WHO’s AI-powered digital health worker

Achieving launch excellence in oncology

Understanding the tumour micro-environment – the pharmaphorum podcast

combination therapy

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

Market Access/ News/ News/ News/ Sales and Marketing

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

Phil Taylor Boehringer Ingelheim, combination therapy, Eli Lilly, metabolic disease, Type 2 diabetes 0 Comment

Eli Lilly and Boehringer Ingelheim’s longstanding alliance in diabetes has delivered another new product, this time a three-drug

X

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

https://pharmaphorum.com/news/lilly-boehringer-bag-fda-okay-for-diabetes-triple-trijardy-xr/

1200x627_IO_image

Oncology/ Partner content/ Press releases

MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conference

Maria Mandic cancer, car t-cell, combination therapy, immuno-oncology, immuno-therapy 0 Comment

MHRA, Pfizer & Autolus Sign Up for Immuno-Oncology 2018

X

MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conference

https://pharmaphorum.com/partner-content/mhra-pfizer-autolus-and-tusk-theraputics-sign-up-for-immuno-oncology-conference/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

GSK's Jemperli/TIM-3 immuno-oncology combo moves to ph3
AstraZeneca pays record 660% premium for gene editing company LogicBio
Roche gets FDA approval for HER2 breast cancer diagnostic
Novo Nordisk achieve headline results with icodec insulin
Bill aims to limit CMS' "overreach" on Alzheimer's drugs

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com